FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/23/2024
Back to search
Official data from USPTO
SITALA BIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SITALA BIO
ST13
US500000079345383Class
5, 42
Filing
79345383
Registration
7256672
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
04/23/2024
Trademark type
Word
Nice classes
5, 42
Filing date
05/19/2022
Registration date
01/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/02/2024
Last transaction
01/02/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
MORRIS, KRISTINA
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Sitala Bio Ltd
Representatives
Tanja Proehl Greer, Burns & Crain, Ltd.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and medicinal preparations for the prevention and treatment of chronic inflammationinflammation and inflammatory diseases; medicinal substances for the prevention and treatment of chronic inflammationinflammation and inflammatory diseases
Class 42
Development of pharmaceutical preparations and medicines; pharmaceutical drug development services; laboratory research services in the field of pharmaceuticals; clinical research in the field of chronic inflammationinflammation and inflammatory diseases; medical research; conducting of clinical trials for pharmaceutical products in the field of chronic inflammationinflammation and inflammatory diseases; pharmaceutical product evaluation services; testing of pharmaceuticals; pharmaceutical research and development services; informationconsultancy and advisory services relating to all of the aforesaid
Publications
History of USPTO decisions and trademark events.
28 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/03/2024
FIMP
FINAL DISPOSITION PROCESSED
04/03/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/02/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/13/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/02/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/27/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/27/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/17/2023
PUBO
PUBLISHED FOR OPPOSITION
10/17/2023
GPNX
NOTIFICATION PROCESSED BY IB
10/16/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/27/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/27/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/27/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/08/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/15/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/15/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/15/2023
RFNP
REFUSAL PROCESSED BY IB
06/06/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/14/2023
RFRR
REFUSAL PROCESSED BY MPU
05/13/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/24/2023
CNRT
NON-FINAL ACTION WRITTEN
03/23/2023
DOCK
ASSIGNED TO EXAMINER
03/09/2023
MAFR
APPLICATION FILING RECEIPT MAILED
07/26/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/22/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/21/2022
Continuous trademark protection
Get notified about every new filing that threatens SITALA BIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.